Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways
Year: 2016
Type: article
Abstract: Insulin and insulin-like growth factor I (IGF1) influence cancer risk and progression through poorly understood mechanisms. To better understand the roles of insulin and IGF1 signaling in breast cancer, we combined proteomic screening with computational network inference to uncover differences in IGF1 and insulin induced signaling. Using reverse phase protein array, we measured the levels of 134 proteins in 21 breast cancer cell lines stimulated with IGF1 or insulin for up to 48 h. We then constructed directed protein expression networks using three separate methods: (i) lasso regression, (ii) conventional matrix inversion, and (iii) entropy maximization. These networks, named here as the time translation models, were analyzed and the inferred interactions were ranked by differential magnitude to identify pathway differences. The two top candidates, chosen for experimental validation, were shown to regulate IGF1/insulin induced phosphorylation events. First, acetyl-CoA carboxylase (ACC) knock-down was shown to increase the level of mitogen-activated protein kinase (MAPK) phosphorylation. Second, stable knock-down of E-Cadherin increased the phospho-Akt protein levels. Both of the knock-down perturbations incurred phosphorylation responses stronger in IGF1 stimulated cells compared with insulin. Overall, the time-translation modeling coupled to wet-lab experiments has proven to be powerful in inferring differential interactions downstream of IGF1 and insulin signaling, in vitro.
Source: Molecular & Cellular Proteomics
Authors: Cemal Erdem, Alison M. Nagle, Angelo J. Casa, Beate C. Litzenburger, Yu-fen Wang, D. Lansing Taylor, Adrian V. Lee, Timothy R. Lezon
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Funders: Commonwealth of Pennsylvania, Lincoln University, National Cancer Research Institute, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences, Office of Extramural Research, National Institutes of Health
Awards: IRS-1 and -2 signaling in mammary development and cancer, G111615301, G1619438925, G1699371352, G277360231, G3276742432, G3770347397, G3842446800, Predoctoral Training in Pharmacological Sciences, G6276907313, Translational Research in Breast Cancer, G7881517065, G8607821337, Cancer Center Support Grant, Autonomous Platform for Pulsatile Soluble Stimulation, G939268909
OpenAlex ID: W2469147100
